Clinical Trials Logo

Clinical Trial Summary

To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.


Clinical Trial Description

The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04485988
Study type Observational
Source Chongqing Medical University
Contact dongying zhang, doctor
Phone 86.27.8901.1596
Email zhangdongying@cqmu.edu.cn
Status Recruiting
Phase
Start date July 1, 2015
Completion date July 2021

See also
  Status Clinical Trial Phase
Recruiting NCT02793934 - The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
Recruiting NCT05122455 - Effects of Edoxaban on Platelet Aggregation Phase 2/Phase 3
Recruiting NCT05201274 - Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI N/A
Completed NCT00289237 - Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease N/A
Completed NCT00331578 - Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent Phase 4
Recruiting NCT05764057 - DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Phase 3
Terminated NCT00670228 - Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction Phase 3